分析验证第二代甲甲酸盐免疫试验的分析验证
Rebecca Wilson1,2, Diane Yamaguchi3, Jamie Garrett3
1Division of Pathology and Laboratory Medicine, Cincinnati Children's Hospital, Cincinnati, OH, United States.
The journal of applied laboratory medicine
|October 28, 2025
概括
这项研究验证了一种新的甲状腺素抗体检测方法,发现它对大多数临床用途都准确. 然而,DAMPA的干扰需要仔细解释,特别是在接受葡萄糖酶治疗的患者中.
科学领域:
- 临床化学 临床化学
- 分析毒理学分析毒理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 甲托雷克萨特是癌症,自身免疫性疾病和移植患者的重要抗叶酸治疗方法.
- 由于潜在的毒性,精确监测甲状腺素是至关重要的.
- 由于代谢物干扰使得血甲酸盐的测量变得复杂,因此免疫检测和LC-MS/MS常见方法.
研究的目的:
- 为了评估第二代甲基酸盐免疫试验的分析性能.
- 为了比较免疫试验的准确性和可靠性与LC-MS/MS.
- 评估主要的甲状腺素代谢物的潜在干扰.
主要方法:
- 通过精度,准确性,线性和干扰测试来评估分析性能.
- 与LC-MS/MS进行了方法比较.
- 测量了与4-脱氧-4-氨基-N10-甲基酸 (DAMPA),7-OH甲醇和叶酸的交叉反应性.
主要成果:
- 免疫测试显示了良好的精度 (%CV 2.6%4.4%) 和线性 (0.031.3μM).
- 观察到DAMPA超过1μM的显著干扰,影响LC-MS/MS的相关性 (R2 = 0.3241).
- 在测试范围内,没有发现7-OH甲醇或叶酸对7-OH甲醇或叶酸的显著干扰.
结论:
- 经过验证的免疫试验适用于大多数临床甲状腺素监测应用.
- 对于DAMPA的干扰,在测试选择和结果解释过程中需要仔细考虑.
- 由于潜在的DAMPA干扰,建议在接受葡萄糖酶治疗的患者中特别小心.
相关概念视频
Data Validation
568
Method validation is a crucial process in analytical chemistry designed to confirm that a given method consistently produces reliable and high-quality results. This process is essential when a method is applied to different sample matrices or when procedural modifications are made, ensuring that the results meet acceptable standards across various applications.
Key parameters for method validation include:
Key parameters for method validation include:
568
Therapeutic Drug Monitoring: Drug Analysis Methods
172
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
172
Therapeutic Drug Monitoring: Affecting Factors
196
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
196


